• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Companies start shipping U.S. flu vaccines: 170 million doses expected

Pathfinder

Editor, Senior Moderator
Companies start shipping U.S. flu vaccines

Sat Jul 31, 2010 2:13am IST

170 million vaccines expected for U.S. market
* Universal vaccination now recommended

By Maggie Fox, Health and Science Editor

WASHINGTON, July 30 (Reuters) - Two flu vaccine makers said on Friday they had started shipping supplies for the U.S. market, one of the earliest starts ever to distributing seasonal influenza vaccine.

And U.S. officials said they were changing the labeling on a vaccine made by Australia's CSL Ltd (CSL.AX) because it appears to have caused a higher than usual rate of seizures in children.

Sanofi Aventis (SASY.PA) said it was shipping 70 million doses of seasonal flu vaccine -- its largest production run ever -- and GlaxoSmithKline (GSK.L) said it was shipping 30 million doses of partner ID Biomedical's FluLaval vaccine.

...

Read more:
http://in.reuters.com/article/swissMktRpt/idINN3019609820100730
 
Back
Top Bottom